Navigation Links
Bruin Biometrics, LLC Achieves Significant Milestone with Receipt of ISO 13485 Certification
Date:12/9/2013

LOS ANGELES, Dec. 9, 2013 /PRNewswire/ -- Bruin Biometrics, LLC ("BBI") an innovative medical device manufacturer, announced today that it has received ISO 13485:2003 and EN ISO 13485:2012 certification, including CMDCAS certification, for its Quality Management System with its notified body SGS. Receipt of ISO 13485 certification demonstrates BBI's commitment to quality in the design, development, manufacture, and distribution of non-invasive diagnostic medical devices. The ISO standard also assures BBI partners and customers that its products and processes conform to international quality standards.

(Logo: http://photos.prnewswire.com/prnh/20131018/LA00429LOGO

"Achieving ISO 13485 certification is a substantial milestone for BBI. It demonstrates BBI's continued commitment to the highest level of quality management and service, and to ensure distribution of safe and effective medical devices," said Armin Beck, Vice President of QA/RA/CA & commercial operation for BBI.

BBI is privately-held and based in Los Angeles, California. For additional information, please visit www.bruinbiometrics.com.

 

 


'/>"/>
SOURCE Bruin Biometrics, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology news :

1. Bruin Biometrics, LLC Awarded CE Mark for the SEM Scanner, an Innovative Diagnostic Tool to Detect Pressure Induced Tissue Damage
2. UCI achieves rare trifecta: 3 scientists receive New Innovator Awards
3. DO-HEALTH a multi-center clinical trial on healthy ageing achieves first milestone
4. Federal Government Organization achieves cleaner and faster Clinical Study Data using Tablet PCs from TabletKiosk
5. Targeted treatment can significantly reduce relapse in children with AML leukemia
6. Children are significantly more likely to develop PTSD if the mother is already afflicted
7. Dartmouth-led study shows diet alone can be significant source of arsenic
8. Amgen Presents Pooled Analysis Showing AMG 145 Significantly Reduced LDL Cholesterol In Over 1,200 Patients
9. Study shows probiotic Lactobacillus reuteri NCIMB 30242 significantly increased vitamin D levels
10. Global cooling as significant as global warming
11. Synthetic biology research community grows significantly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... June 22, 2016 On Monday, the Department ... industry to share solutions for the Biometric Exit Program. ... and Border Protection (CBP), explains that CBP intends to ... the United States , in order ... defeat imposters. Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/9/2016)... June 9, 2016  Perkotek an innovation leader in attendance control systems is proud ... work hours, for employers to make sure the right employees are actually signing in, ... ... ... ...
(Date:6/2/2016)... 2, 2016   The Weather Company , an IBM ... an industry-first capability in which consumers will be able to ... ask questions via voice or text and receive relevant information ... Marketers have long sought an advertising solution that ... be personal, relevant and valuable; and can scale across millions ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... ... findings on what they believe could be a new and helpful biomarker for ... research. Click here to read it now. , Biomarkers are components ...
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... ... , ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension ... are higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... bottom of the cuvette holder. , FireflySci has developed several Agilent flow cell ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
Breaking Biology Technology: